Dr
Achim
Krebs

Partner & Patent Attorney

The Hague Office

Telephone. +31(0) 702 400 899
Mobile. +31(0) 616 364 665
Email. [email protected]

Experience

Achim's practice covers a wide range of chemical, pharmaceutical and high tech inventions, and he is acting for a diverse range of companies across these technologies, from start-ups to multinationals.

Achim regularly advises clients on the IP aspects of complex technologies, and on the creation and management of cost-effective IP portfolios.

He also regularly represents clients in Opposition and Appeal Proceedings before the European Patent Office, and often supports clients in multi-jurisdictional contentious situations.

Another field involves due diligence investigations into IP portfolios of technology companies, primarily for venture capital and private equity investors.

Achim is presently serving as President of the LES Benelux.

Achim is qualified as a Dutch, Belgian and European Patent Attorney, and he is a registered European Trade Mark and Design Attorney.

Specialisms

  • Catalysis
  • Electrochemistry
  • Energy
  • Food science
  • Material science
  • Petrochemicals
  • Polymer chemistry
  • Printing technologies

Industries

  • Agrochemicals icon Agrochemicals
  • Food & drink icon Food & drink
  • Pharmaceuticals icon Pharmaceuticals

Services

  • Designs & design rights
  • Due diligence
  • In-house legal support
  • Patent oppositions & appeals
  • Patents
  • Portfolio management
  • Searching & competitor monitoring
  • Strategy
  • Trade marks
  • Transactional IP & commercial support
  • Utility models

Qualifications

Patent Attorney

Dutch
European
Belgian

Trade Mark Attorney

European


OTHER

Dipl. Chem.

PHD

Dr. Rer. Nat.

POSTGRADUATE DIPLOMA OR CERTIFICATE

CEIPI Patent Litigation

POSTGRADUATE DIPLOMA OR CERTIFICATE

Polymer RSC

Recognition

IAM Patent 1000

"Achim Krebs appreciates what clients really need and gives made-to-measure advice. He is strategic and has a strong commercial understanding of intellectual property and how it can be used to serve business purposes.” He protects chemical, pharmaceutical and mechanical inventions from his base at HGF in The Hague.

View recognition online

Publications

IAM Patent 1000 2020

View publication online

IAM Patent 1000 2019

View publication online

Chair WIPO ADR Seminar

View publication online

LES China and CNIPA Licensing Courses 2017 to 2019

Conferences: 2020

October 12th 2020

LES Benelux Licensing Course 2018

Speaker

Event details

Conferences: 2019

November 4th 2019

LES Benelux Licensing course 2019 - The Hague

Speaker

Event details

Conferences: 2016

April 21st 2016

Topic Meeting IP & Tax – Quo Vadis!

Speaker

Conferences: 2013

September 6th 2013

Conference on Green Technologies - IP, Technology Transfer and Dispute Resolution in the Energy Sector

Speaker

Event details

Conferences: 2012

March 22nd 2012

Thomson Reuters IP Seminar

Speaker

Event details

CSR

President of the Licensing Executive Society for the Benelux for 2020/2021. Secretary LES Benelux 2008-2018.

Related News

Managing Intellectual Property IP Stars & Firm Rankings 2021

Managing Intellectual Property IP Stars 2021, comprising the highly recommended IP professionals, has now been published. HGF is delighted to have 14 European attorneys listed. IP STARS is the leading …

Read article

Medical technology most patented subject matter at EPO in 2020

Pharmaceutical and biotechnology patent applications also make top 10 most patented. Recent statistics published by the EPO show that a total of 14,295 European patent applications were filed in 2020 …

Read article

Searching for the distinctive

How to streamline the trade mark selection process by conducting effective, in-house ‘dirty searches’. Selecting the right trade mark for your new healthcare product is a critically important task. Consumers …

Read article

The EPO ‘How To’ guide for antibody applications in Europe

The 2021 EPO Guidelines provide much needed guidance on how to protect antibodies in Europe. Biological drugs including therapeutic antibodies have become increasingly important to the pharmaceutical industry. The European …

Read article

Personalised drug patenting in Europe

Opportunities for additional pharmaceutical product patent protection in Europe, based on the use of a drug to treat a patient exhibiting a biomarker indicative of drug response. Recent years have …

Read article

The Internet of Medical Things

Exploring the growth of patents for connected medical devices, and how best to protect them. The Internet of Things (IoT) is expected to change our lives by creating a connected …

Read article

Covid-19 vaccine patent waivers

To waive, or not to waive, that is the question. The earliest identified date of a patient presenting with symptoms of a “novel coronavirus” in Wuhan, China is reported to …

Read article
Event - 8th June 2021

WIPR Trademarks Live

HGF is sponsoring WIPR Trademarks Live conference 2021 with Partner Lee Curtis speaking on 8th June. WIPR Trademarks Live is designed to provide critical and timely insights from leading trademark …

Event details

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.